The U.S. Centers for Disease Control and Prevention (CDC) awarded a $2,179,825.02 definitive, time and materials contract to The Amyotrophic Lateral Sclerosis (ALS) Association, a non-profit organization, to provide communications and outreach services in support of the National ALS Registry program. This contract does not have a set-aside designation. The ALS Association is responsible for delivering these services until September 26, 2026. Through this contract, the ALS Association will...
The Centers for Disease Control and Prevention (CDC) awarded a $8,046,975.18 time and materials contract to Mcking Consulting Corporation, a veteran-owned small business, to maintain and continue a national biorepository of specimens from persons with amyotrophic lateral sclerosis (ALS) enrolled in the National ALS Registry. This contract was awarded under the CDC's Surveillance, Health Equity, Prevention, and Response for Emerging Diseases (SHEPheRD) program, a $99 million multiple-award...
The federal contract award with ID HHSD200201689510C was issued by the Centers for Disease Control and Prevention (CDC) to the Les Turner Amyotrophic Lateral Sclerosis (ALS) Foundation, Ltd. for $518,264.07 on a firm fixed-price basis. The contract, which does not have a set-aside designation, is for unspecified "other functions" related to the Les Turner ALS Foundation and has an ultimate completion date of September 29, 2021. The Les Turner ALS Foundation is a non-profit organization...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Vim Associates Inc., a Small Disadvantaged Business and 8(a) Program participant. The contract is for the National ALS Registry Web Portal Support, with a total ceiling value of $3,786,815.48 and a period of performance ending on August 31, 2029. The contract was awarded on September 20, 2024 using a Definitive Contract and Labor Hours pricing type. The place of performance is San Antonio, Texas.
This is a delivery order contract awarded by the Defense Health Agency (DHA) to Leidos, Inc. for programmatic review services in support of the Fiscal Year 2020 Amyotrophic Lateral Sclerosis (ALS) Research Program, which is part of the Congressionally Directed Medical Research Programs (CDMRP). The contract has a ceiling value of $520,785.96 and a period of performance through April 30, 2023. It is a cost-plus-fixed-fee contract. No set-aside designation was used. Leidos, Inc. is the prime...
This is a $1,154,934.18 federal contract awarded on July 19, 2021 by the Centers for Disease Control and Prevention (CDC) to Brunet-Garcia Advertising LLC, a minority-owned advertising and public relations firm, under an 8(a) sole source set-aside. The contract, titled "ALS - NATIONAL REGISTRY MARKETING AND COMM.", is for time and materials-based marketing, communications, and outreach services in support of the CDC's programs, with a performance period ending on July 17, 2026....
This is a federal contract award from the Defense Health Agency to Leidos, Inc. for fiscal year 2024 Amyotrophic Lateral Sclerosis (ALS) research program support services. The contract is a delivery order with a cost-plus-fixed-fee pricing type and a ceiling value of $301,560.09. The period of performance runs through April 30, 2025. This contract is not set aside for any specific business category. Leidos, Inc. is the prime contractor and is a global leader in information technology,...
This federal contract was awarded to Hite Consulting, Inc., an 8(a) certified, economically disadvantaged woman-owned small business, by the Centers for Disease Control and Prevention (CDC) for communications and consulting services related to the ALS Registry program. The contract has a ceiling value of $1,808,381.41 and a period of performance through September 12, 2026. This contract was awarded under the General Services Administration's Multiple Award Schedule (MAS) and is a Delivery...
This federal contract award is for the AMYOTROPHIC LATERAL SCLEROSIS RESEARCH PROGRAM, a medical research effort led by the Defense Health Agency. The $274,526.55 contract was awarded to Leidos, Inc., a global technology and engineering solutions provider, to support this research program. The contract is a cost-plus-fixed-fee delivery order, with an ultimate completion date of April 30, 2026. Leidos will provide a range of technical, scientific, and administrative services to the Defense Health...
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $242,000.00 firm fixed price purchase order to the University of Texas Southwestern Medical Center (UT Southwestern) to conduct a regional case finding pilot program for patients with acute flaccid myelitis (AFM). UT Southwestern, a not-for-profit academic medical center, will work with the Siegel Rare Neuroimmune Diseases Association to rapidly identify suspected AFM cases, collect clinical...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,730,910.00 Firm Fixed Price contract to the Muscular Dystrophy Association Inc. (MDA) for ALS MDA National ALS Registry Communications and Outreach Technical Support. This sole source contract was awarded on September 24, 2018 to leverage MDA's extensive nationwide network of offices, clinics, and Centers of Excellence to promote the National Amyotrophic Lateral Sclerosis (ALS) Registry and increase enrollment numbers, fulfilling a congressional mandate under the ALS Registry Act. The contract has a 60-month period of performance including one base year and four 12-month option years. This contract does not have a set-aside designation.